These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15057440)

  • 41. Update on drug-eluting coronary stents.
    Kipshidze NN; Tsapenko MV; Leon MB; Stone GW; Moses JW
    Expert Rev Cardiovasc Ther; 2005 Sep; 3(5):953-68. PubMed ID: 16181039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Through the drug-eluting stent labyrinth.
    Guagliumi G; Musumeci G; Vassileva A; Tespili M; Valsecchi O
    Ital Heart J; 2003 Apr; 4(4):236-45. PubMed ID: 12784776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rotational atherectomy is useful to treat restenosis lesions due to crushing of a sirolimus-eluting stent implanted in severely calcified lesions: experimental study and initial clinical experience.
    Okamura A; Ito H; Fujii K
    J Invasive Cardiol; 2009 Oct; 21(10):E191-6. PubMed ID: 19805850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Brachytherapy after coronary interventions: current state and future perspectives].
    Naber CK; Kaiser CA; Sauerwein W; Meusers P; Eggebrecht H; Haude M; Erbel R; Baumgart D
    Z Kardiol; 2003 Jan; 92(1):1-15. PubMed ID: 12545296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Debulking for in-stent restenosis in the brachytherapy era: does it still have a role?
    Tuli A; Subramaniyam V; Bakir S; Block PC; Crocker IR
    J Invasive Cardiol; 2003 Apr; 15(4):209-12. PubMed ID: 12668849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug-eluting stents. A review of the current literature.
    Laroia ST; Laroia AT
    Cardiol Rev; 2004; 12(1):37-43. PubMed ID: 14667263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of coronary artery in-stent restenosis.
    Kokkinidis DG; Waldo SW; Armstrong EJ
    Expert Rev Cardiovasc Ther; 2017 Mar; 15(3):191-202. PubMed ID: 28116914
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug-eluting stents: present and future.
    Pendyala L; Jabara R; Shinke T; Chronos N; Robinson K; Li J; Hou D
    Cardiovasc Hematol Agents Med Chem; 2008 Apr; 6(2):105-15. PubMed ID: 18473775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Chronic coronary multi-vessel disease with left main artery stenosis: For PCI].
    Hamm CW
    Dtsch Med Wochenschr; 2010 Apr; 135(13):626. PubMed ID: 20333600
    [No Abstract]   [Full Text] [Related]  

  • 50. Cost-effectiveness of drug-eluting stents: if only all things were equal.
    Chew DP
    Med J Aust; 2005 Apr; 182(8):376-7. PubMed ID: 15850431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Drug eluting stents as the new direction of cardiovascular prothesis research].
    Guzik Ł; Nasternak M; Maciejewski M
    Pol Merkur Lekarski; 2010 Apr; 28(166):297-301. PubMed ID: 20491341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coronary bifurcation lesions: innovative approaches and the future of bifurcation devices.
    Cortese B; Limbruno U
    Future Cardiol; 2010 Mar; 6(2):221-30. PubMed ID: 20230263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current treatment of in-stent restenosis.
    Alfonso F; Byrne RA; Rivero F; Kastrati A
    J Am Coll Cardiol; 2014 Jun; 63(24):2659-73. PubMed ID: 24632282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Drug releasing stents].
    Ban Hayashi E
    Arch Cardiol Mex; 2003; 73 Suppl 1():S17-20. PubMed ID: 12966638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug-eluting balloons in coronary interventions: the quiet revolution?
    Alfonso F; García-Guimaraes M; Navarrete G; Cuesta J; Bastante T; Benedicto A; Rivero F; Cortese B
    Expert Opin Drug Deliv; 2017 Jul; 14(7):841-850. PubMed ID: 27718756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute outcome with the flexicut directional coronary atherectomy catheter for the treatment of coronary in-stent restenosis.
    O'Brien ER; Glover C; Labinaz M
    J Invasive Cardiol; 2001 Sep; 13(9):618-22. PubMed ID: 11533496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vascular brachytherapy: applications in the era of drug-eluting stents.
    Waksman R
    Rev Cardiovasc Med; 2002; 3 Suppl 5():S23-30. PubMed ID: 12478232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coronary artery stents: evaluating new designs for contemporary percutaneous intervention.
    Kandzari DE; Tcheng JE; Zidar JP
    Catheter Cardiovasc Interv; 2002 Aug; 56(4):562-76. PubMed ID: 12124974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paclitaxel drug-coated balloons: a review of current status and emerging applications in native coronary artery de novo lesions.
    Loh JP; Waksman R
    JACC Cardiovasc Interv; 2012 Oct; 5(10):1001-12. PubMed ID: 23078727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Letter by Alfonso et al regarding article, "Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis".
    Alfonso F; Pérez-Vizcayno MJ; Fernández C
    Circulation; 2010 Feb; 121(6):e33; author reply e34-5. PubMed ID: 20159838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.